Blue Trust’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.2K Buy
755
+34
+5% +$547 ﹤0.01% 1701
2026
Q2
$14.8K Sell
721
-400
-36% -$9.16K ﹤0.01% 1749
2026
Q1
$24.7K Sell
1,121
-13
-1% -$226 ﹤0.01% 1578
2025
Q4
$13.4K Sell
1,134
-3
-0.3% -$39 ﹤0.01% 1791
2025
Q3
$18K Buy
1,137
+394
+53% +$5.72K ﹤0.01% 1694
2025
Q2
$8.51K Buy
743
+426
+134% +$4.8K ﹤0.01% 1913
2025
Q1
$4.29K Sell
317
-21
-6% -$349 ﹤0.01% 2126
2024
Q4
$5.71K Sell
338
-831
-71% -$16.2K ﹤0.01% 2063
2024
Q3
$26.4K Buy
1,169
+731
+167% +$14.9K ﹤0.01% 1840
2024
Q2
$11.5K Buy
438
+100
+30% +$2.62K ﹤0.01% 1883
2024
Q1
$8.88K Sell
338
-268
-44% -$7.64K ﹤0.01% 1475
2023
Q4
$17K Sell
606
-234
-28% -$6.35K ﹤0.01% 1354
2023
Q3
$31K Sell
840
-3
-0.4% -$103 ﹤0.01% 1022
2023
Q2
$25K Sell
843
-5
-0.6% -$153 ﹤0.01% 959
2023
Q1
$26K Sell
848
-51
-6% -$1.68K ﹤0.01% 1270
2022
Q4
$22K Buy
899
+480
+115% +$14.4K ﹤0.01% 1259
2022
Q3
$13K Buy
419
+35
+9% +$1.16K ﹤0.01% 1252
2022
Q2
$12K Hold
384
– – ﹤0.01% 1130

Other funds holding CC

Blue Trust's CC Position: Q3 2026 in Review

Blue Trust increased its Chemours (CC) stake by 4.7% in Q3 2026, buying an estimated $547 and bringing the position to 755 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1701.

Blue Trust first reported a position in CC in Q2 2022 and has held it in 18 quarters since. The position peaked at $31K in Q3 2023. 446 funds tracked by Wall St. Rank hold CC as of Q3 2026.

  • Blue Trust held 755 shares of Chemours worth $10.2K as of Q3 2026.
  • Blue Trust bought 34 Chemours shares in Q3 2026, an estimated $547.
  • Chemours made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1701 holding.
  • Blue Trust first reported a position in Chemours in Q2 2022 and has held it in 18 quarters since.
  • Blue Trust's Chemours position peaked at $31K in Q3 2023.
  • 446 funds tracked by Wall St. Rank held Chemours as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.